RAHIKA Capmatinib 200 mg Tablets

Capmatinib is an advanced targeted therapy medicine used in the treatment of specific types of lung cancer. RAHIKA Capmatinib 200 mg Tablets contain Capmatinib, a MET inhibitor that works by blocking abnormal MET signaling pathways responsible for the growth and spread of cancer cells. It is mainly prescribed for patients with metastatic non-small cell lung cancer (NSCLC) having MET exon 14 skipping mutations.

RAHIKA Capmatinib 200 mg Tablets help slow tumor progression, improve treatment response, and support personalized cancer therapy. The medicine is usually prescribed by oncologists after genetic testing confirms MET gene alterations.

Contact Details – Place Your Order Today

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: GlobMedIndia

Composition and Content

• Brand Name: RAHIKA Capmatinib 200 mg Tablets
• Generic Name: Capmatinib
• Strength: 200 mg
• Dosage Form: Oral Tablets
• Category: Anti-Cancer / Targeted Therapy Medicine
• Route of Administration: Oral Use

How RAHIKA Capmatinib 200 mg Tablets Work

Capmatinib is a MET inhibitor that blocks the MET receptor signaling pathway involved in cancer cell growth and spread. By targeting abnormal MET gene alterations, the medicine helps stop tumor development and slows disease progression in lung cancer patients.

Uses of RAHIKA Capmatinib 200 mg Tablets

RAHIKA Capmatinib Tablets are commonly used for:

• Metastatic Non-Small Cell Lung Cancer (NSCLC)
• MET Exon 14 Skipping Mutation Positive Lung Cancer
• Advanced Lung Cancer Treatment
• Personalized Targeted Cancer Therapy

How to Use RAHIKA Capmatinib Tablets

• Take the tablets exactly as prescribed by your oncologist.
• Swallow whole with water.
• Can be taken with or without food.
• Do not crush, chew, or break the tablets.
• Follow regular medical monitoring and scans during treatment.

Recommended Dosage

The dosage of Capmatinib depends on the patient’s condition, mutation profile, and oncologist recommendation.

Typical dosage schedules may include:

• 400 mg orally twice daily
• Continued until disease progression or unacceptable toxicity
• Dose adjustments may be required for side effects

⚠️ Important: Use only under medical supervision.

Advantages of RAHIKA Capmatinib 200 mg Tablets

• Targeted therapy for MET-positive lung cancer
• Helps slow tumor progression
• Personalized precision medicine approach
• Oral administration for patient convenience
• May improve progression-free survival
• Effective for advanced NSCLC cases

Possible Side Effects

Some patients may experience:

• Nausea
• Fatigue
• Swelling in hands or feet
• Vomiting
• Loss of appetite
• Shortness of breath
• Increased liver enzymes
• Photosensitivity reactions

Consult your doctor immediately if severe side effects occur.

Storage Conditions

• Store below 25°C
• Keep away from direct sunlight
• Store in a dry place
• Keep out of reach of children
• Do not use expired medicine

Alternative Indian Brands for Capmatinib Tablets

Popular alternatives to Capmatinib may include:

• Capmax Tablets
• Capmatib Tablets
• Generic Capmatinib Tablets
• MET inhibitor targeted therapy alternatives

Availability may vary depending on local regulations and stock.

Why Choose GlobMedIndia?

• Trusted Global Medicine Exporter
• Genuine Oncology Medicines
• International Shipping Available
• Safe & Secure Packaging
• Affordable Export Pricing
• Fast Worldwide Delivery
• Professional Customer Support

We export anti-cancer medicines across:

• South Africa
• Botswana
• Lesotho
• Mozambique
• Namibia
• Eswatini
• Zimbabwe

Major delivery locations include:

• Johannesburg
• Cape Town
• Pretoria
• Polokwane
• Germiston
• Mbombela

Buy Now RAHIKA Capmatinib 200 mg Tablets from GlobMedIndia – Trusted Exporter of Anti-Cancer Medicines Worldwide